SG45439A1 - Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers - Google Patents

Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers

Info

Publication number
SG45439A1
SG45439A1 SG1996008586A SG1996008586A SG45439A1 SG 45439 A1 SG45439 A1 SG 45439A1 SG 1996008586 A SG1996008586 A SG 1996008586A SG 1996008586 A SG1996008586 A SG 1996008586A SG 45439 A1 SG45439 A1 SG 45439A1
Authority
SG
Singapore
Prior art keywords
cimaterol
nantiomers
separation
pharmaceutical composition
performance enhancers
Prior art date
Application number
SG1996008586A
Other languages
English (en)
Inventor
Wolfgang Resemann
Adolf Durr
Gunther Engelhardt
John Francis Quirke
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of SG45439A1 publication Critical patent/SG45439A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
SG1996008586A 1990-05-04 1991-04-26 Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers SG45439A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
SG45439A1 true SG45439A1 (en) 1998-01-16

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008586A SG45439A1 (en) 1990-05-04 1991-04-26 Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers

Country Status (27)

Country Link
US (4) US5248695A (enExample)
EP (2) EP0455155B1 (enExample)
JP (1) JP2944777B2 (enExample)
KR (1) KR0183024B1 (enExample)
AR (1) AR247728A1 (enExample)
AT (2) ATE124932T1 (enExample)
AU (1) AU645313B2 (enExample)
BG (1) BG60743B1 (enExample)
CA (1) CA2041818C (enExample)
CZ (1) CZ286389B6 (enExample)
DE (3) DE4014252A1 (enExample)
DK (2) DK0455155T3 (enExample)
ES (2) ES2109412T3 (enExample)
FI (1) FI109600B (enExample)
GR (2) GR3017064T3 (enExample)
HU (1) HU214335B (enExample)
ID (1) ID966B (enExample)
IE (2) IE69017B1 (enExample)
IL (1) IL98030A (enExample)
NO (1) NO174803B (enExample)
NZ (1) NZ238032A (enExample)
PT (1) PT97544B (enExample)
RU (1) RU2002737C1 (enExample)
SG (1) SG45439A1 (enExample)
SK (1) SK279258B6 (enExample)
TW (1) TW197415B (enExample)
ZA (1) ZA913337B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
EP0979081A4 (en) 1997-04-30 2003-05-02 Bridge Pharma Inc COMPOSITION AND METHODS USING EUTOMER
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
HUP0300832A2 (hu) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
WO2004103057A2 (en) * 2003-05-15 2004-12-02 The University Of Georgia Research Foundation, Inc. Compositions and methods for inducing adipose tissue cell death
DK1663197T3 (da) * 2003-09-09 2008-01-07 Fumapharm Ag Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
WO2006108424A2 (en) * 2005-04-13 2006-10-19 Astion Pharma A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
WO2006128180A2 (en) * 2005-05-27 2006-11-30 Children's Medical Center Corporation Methods for the treatment of disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
MY176727A (en) 2012-12-03 2020-08-20 Pfizer Selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (enExample) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
IE80651B1 (en) 1998-11-04
CA2041818C (en) 2003-02-11
JPH04225944A (ja) 1992-08-14
EP0455155A1 (de) 1991-11-06
CS129291A3 (en) 1991-11-12
NO174803C (enExample) 1994-07-13
NO911746L (no) 1991-11-05
NO174803B (no) 1994-04-05
GR3017064T3 (en) 1995-11-30
IE911507A1 (en) 1991-11-06
KR910019966A (ko) 1991-12-19
JP2944777B2 (ja) 1999-09-06
US5248695A (en) 1993-09-28
US5648386A (en) 1997-07-15
AR247728A1 (es) 1995-03-31
HUT60999A (en) 1992-11-30
ZA913337B (en) 1993-01-27
DE4014252A1 (de) 1991-11-07
PT97544B (pt) 1998-08-31
SK279258B6 (sk) 1998-08-05
FI912151L (fi) 1991-11-05
US5292753A (en) 1994-03-08
BG94342A (en) 1994-06-30
ES2075255T3 (es) 1995-10-01
DE59108853D1 (de) 1997-10-23
PT97544A (pt) 1992-01-31
CA2041818A1 (en) 1991-11-05
FI109600B (fi) 2002-09-13
BG60743B1 (bg) 1996-02-29
NO911746D0 (no) 1991-05-03
DK0455155T3 (da) 1995-11-13
TW197415B (enExample) 1993-01-01
US5395957A (en) 1995-03-07
FI912151A0 (fi) 1991-05-03
EP0455155B1 (de) 1995-07-12
DE59105957D1 (de) 1995-08-17
HU214335B (hu) 1998-03-02
HU911502D0 (en) 1991-11-28
EP0589488A1 (de) 1994-03-30
EP0589488B1 (de) 1997-09-17
KR0183024B1 (ko) 1999-05-15
RU2002737C1 (ru) 1993-11-15
NZ238032A (en) 1996-02-27
ID966B (id) 1996-09-30
CZ286389B6 (cs) 2000-03-15
IL98030A0 (en) 1992-06-21
AU7611191A (en) 1991-11-07
IL98030A (en) 1995-12-31
IE69017B1 (en) 1996-07-24
ES2109412T3 (es) 1998-01-16
ATE158277T1 (de) 1997-10-15
ATE124932T1 (de) 1995-07-15
DK0589488T3 (da) 1998-05-04
GR3025547T3 (en) 1998-03-31
AU645313B2 (en) 1994-01-13

Similar Documents

Publication Publication Date Title
AU626396B2 (en) Composition and use
HU9602188D0 (en) Novel carbamate derivative and medicinal composition containing the same
AP9200426A0 (en) Substance or composition and uses thereof
SG48141A1 (en) Composition of difluoromethane and tetrafluoroeth- ane
EP0304802A3 (en) Pharmaceutical composition and the use thereof
ZA913337B (en) Separation of enantiomers of cimaterol,(-)-cimaterol and the use thereof
ZA929883B (en) Pharmaceutical composition and process for the preparation thereof
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
GB2289472B (en) CRT adhesive composition and CRT obtained by the use thereof
GB9125330D0 (en) Novel dna clones and uses thereof
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
AU1282395A (en) Novel benzamide derivative and medicinal composition containing the same
AU631448B2 (en) Application aid and the use thereof
ZA924491B (en) Compositions and use thereof
AU647559B2 (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
EP0438628A3 (en) Polymerisable mixture and its preparation
AU1106392A (en) Composition and use
ZA915677B (en) Solid pharmaceutical composition
GB9016027D0 (en) Composition and use
EP0438629A3 (en) Polymerisable mixture and its preparation
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
ZA922354B (en) Pharmaceutical composition and process for the preparation thereof
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
ITMI912986A1 (it) Composizione per aerosol e procedimento per la sua preparazione